|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Epidemiology of hepatitis C in Croatia in the European context显示文摘We analyzed prevalence, risk factors and hepatitis C virus(HCV) genotype distribution in different population groups in Croatia in the context of HCV epidemiology in Europe, with the aim to gather all existing information on HCV infection in Croatia which will be used to advise upon preventive measures. It is estimated that 35000-45000 of the Croatian population is chronically infected with HCV. Like in other European countries, there have been changes in the HCV epidemiology in Croatia over the past few decades. In some risk groups(polytransfused and hemodialysis patients), a significant decrease in the HCV prevalence was observed after the introduction of routine HCV screening of blood/blood products in 1992. Injecting drug users(IDUs) still represent a group with the highest risk for HCV infection with prevalence ranging from 29% to 65%. Compared to the prevalence in theCroatian general population(0.9%), higher prevalence rates were found in prison populations(8.3%-44%), human immunodeficiency virus-infected patients(15%), persons with high-risk sexual behavior(4.6%) and alcohol abusers(2.4%). Low/very low prevalence was reported in children and adolescents(0.3%) as well as in blood donors(0%-0.009%). In addition, distribution of HCV genotypes has changed due to different routes of transmission. In the general population, genotypes 1 and 3 are most widely distributed(60.4%-79.8% and 12.9%-47.9%, respectively). The similar genotype distribution is found in groups with high-risk sexual behavior. Genotype 3 is predominant in Croatian IDUs(60.5%-83.9%) while in the prison population genotypes 3 and 1 are equally distributed(52.4% and 47.6%). Data on HCV prevalence and risk factors for transmission are useful for implementation of preventive measures and HCV screening. | Tatjana Vilibic-Cavlek Jasmina Kucinar Bernard Kaic Maja Vilibic Nenad Pandak Ljubo Barbic Vladimir Stevanovic Jasmina Vranes | 2015 | World Journal of Gastroenterology2015，21，32： | 2 |
| 2 | Postantibiotic and post-beta-lactamase inhibitor effect of carbapenems against Pseudomonas aeruginosa strains producing VIM-met-allo beta-lactamases显示文摘 | Bedeni B Vranes J Sviben M | 2008 | Chemotherapy2008，54，3： | 1 |
| 3 | Adolescent substance abuse, the importance of family, school and peers: data from the health behaviour in school children 显示文摘 | Jovic-Vranes AS Vranes B Marinkovic J | 2005 | Soz Praventivmed2005，50，2： | 1 |
| 4 | Vascular endothelial growth factor and its receptors in control and diabetic rat eyes显示文摘 | Gilbert RE Vranes D Berka JL Kelly DJ Cox A Wu LL | 1998 | Lab Invest1998，78，8： | 1 |
| 5 | Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes显示文摘 | Cooper ME Vranes D Youssef S | 1999 | Diabet1999，48，23： | 1 |
| 6 | Natural killer cell number and activity in multiple sclerosis显示文摘 | Vranes Z Poljakovic Z Marusic M | 1989 | J Neurol Sci1989，94，： | 1 |
| 7 | increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR- 2 in experimental diabetes显示文摘 | Cooper ME Vranes D Youssef S | 1999 | Diabetes1999，48，： | 1 |
| 8 | Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 and in experimental diabetes显示文摘 | Cooper ME Vranes D Youssef S | 1999 | Diabetes1999，48，： | 1 |
| 9 | Increased renal expression of vascular endothelial growth factor(VEGF)and its receptor VEGER-2 in experimental diabetes显示文摘 | Cooper ME Vranes D Youssel S | 1999 | Diabetes1999，48，11： | 1 |
| 10 | Intravenous leiomyornatosis with extension to the heart: rare or underestimated显示文摘 | Kocica MJ Vranes MR Kostic D | 2005 | J Thorac Cardicovasc Surg2005，130，6： | 1 |
| 11 | Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 and in experimental diabetes显示文摘 | Cooper ME Vranes D Youssef S | 1999 | Diabetes1999，48，： | 1 |
| 12 | Increased renal expression of vascular endothelial growthfactor(VEGF)and its receptor VEGFR-2 in experimental diabetes显示文摘 | Vranes D Youssef S | 1999 | Diabetes1999，48，11： | 1 |
| 13 | Cerebral aneurysm associated with cardiac myxoma: Case report显示文摘 | Ivanovic BA Tadic M Vranes M | 2011 | Bosh J Basic Med Sci2011，11，： | 1 |
| 14 | Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes 显示文摘 | Cooper M E Vranes D Youssef S | 1999 | Diabetes1999，48，11： | 1 |
| 15 | Increased renal expression of vascular endothelial growth factor and its receptor VEGFR-2 in experimental diabetes显示文摘 | COOPER ME VRANES D YOUSEF S | 1999 | Diabetes1999，48，： | 1 |
| 16 | Intravenous leiomyomatosis withextension to the heart: rare or underestimated 显示文摘 | Kocica M J Vranes MR Kostic D | 2005 | J Thorac Cardiovasc Surg2005，130，6： | 1 |
| 17 | Hemagglutination ability and adherence to the Buffalo green monkey cell line of uropathogenic Escherichia coli 显示文摘 | Vranes J | 1997 | AP- MIS1997，105，： | 1 |
| 18 | Vascular endothelial growth factor and its receptors in control snd diabetic rat eyes显示文摘 | Gilbert RE Vranes D Berkca JL | 1998 | Lab Invest1998，78，8： | 1 |
| 19 | Sensitivity and specificity of various Beta-Lactam antibiotics and phenotypical methods for detection of TEM, SHV and CTX-M extended-spectrum beta- lactamases显示文摘 | Bedenic B Vranes J Mihaljevic L | 2007 | J Chemother2007，19，2： | 1 |
| 20 | Increased renal expression of vascular endothelial growth factor(VEGF) and its receptor VEGFR-2 in experimental diahetes显示文摘 | Cooper ME Vranes D Youssef S | 1999 | Diabetes1999，48，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员